Skip to main content
Clinical Trials/NL-OMON22130
NL-OMON22130
Not Yet Recruiting
N/A

Mechanistic insights in mitral valve prolapse and associated left ventricular remodelling: Barlow’s Disease versus Fibroelastic Deficiency

niversity Hospital Antwerp0 sites200 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Heart valve disease: mitral valve prolapse
Sponsor
niversity Hospital Antwerp
Enrollment
200
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversity Hospital Antwerp

Eligibility Criteria

Inclusion Criteria

  • \* Non\-syndromic mitral valve prolapse (e.g. no Marfan syndrome)
  • \* Age 18\-80 years old

Exclusion Criteria

  • \* History of cardiac surgery
  • \* Concomitant valve disease (grade ‘moderate’ or ‘severe’)
  • \* Ischaemic heart disease
  • \* Hypertrophic cardiomyopathy
  • \* Intra\-cardiac device
  • \* History of myocarditis
  • \* Left bundle branch block
  • \* Chronic kidney disease stage 4\-5
  • \* Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials